Ad
related to: resources for people with asthma in atlanta ohio state
Search results
Results from the WOW.Com Content Network
Treat an asthma attack by visiting the hospital. Every year, more than 1.6 million Americans wind up in the emergency room because of an asthma attack, according to the CDC.If your attack is so ...
The Allergy & Asthma Network unites and advocates on behalf of the 60 million Americans with allergies, asthma, and related conditions. The Network is tax-exempt, falling under section 501(3)(c) of the United States Internal Revenue Code. The organization was founded in 1985, by Nancy Sander, [1] the mother of a
A 2023 review found a need for more asthma-specific research on pulmonary function outcomes like oxygen uptake, asthma symptom control, and asthma exacerbations (also called flare-ups or asthma ...
The Asthma and Allergy Foundation of America (AAFA) is the leading patient organization for people with asthma and allergies and the oldest asthma and allergy patient group in the world. AAFA is dedicated to saving lives and reducing the burden of disease for people with asthma, allergies, and related conditions through research, education ...
Anti-asthmatic agents, also known as anti-asthma drugs, refer to drugs that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies and ...
Click to skip ahead and jump to the 10 best U.S. cities to live with asthma. Navigating through life with asthma can be a life-long challenge in itself. Sometimes it becomes very important to ...
The Buteyko method emphasizes the role of carbon dioxide and hyperventilation in respiratory diseases as well as overall health. It is known that hyperventilation can lead to low carbon dioxide levels in the blood (or hypocapnea), which can subsequently lead to disturbances of the acid-base balance in the blood and lower tissue oxygen levels.
Xolair, which is developed and co-promoted by Genentech and Novartis in the US, was originally approved in 2003 for the treatment of moderate to severe persistent allergic asthma in certain people.
Ad
related to: resources for people with asthma in atlanta ohio state